Opioid Suits Against Sackler Family's Purdue May Cost Teva Up to $3 Billion

Purdue Pharma said to be exploring bankruptcy filing as litigation pressures mount

Yoram Gabison
Reuters
Send in e-mailSend in e-mail
FILE PHOTO: A man cleans near the logo of Teva Pharmaceutical Industries at their plant in Jerusalem December 14, 2017.
FILE PHOTO: A man cleans near the logo of Teva Pharmaceutical Industries at their plant in Jerusalem December 14, 2017. Credit: Reuters

Comments